Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of Urgeometer in Overactive Bladder with Solifenacin
NCT00909428Phase 4Completed
- Sponsor
- Loyola University Chicago
- Start
- Jan 2007
- Primary completion
- Jul 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in overactive bladder syndrome (OAB), sponsored by Loyola University Chicago. Started Jan 2007; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT00909428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00909428.